An electrocardiogram or ECG test is done to check the hearts electrical activity to rule out heart conditions The results ...
By Dennis Thompson HealthDay ReporterWEDNESDAY, April 15, 2026 (HealthDay News) — People with a common heart rhythm disorder ...
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized ...
Zeto has received the US Food and Drug Administration (FDA) 510 (k) clearance for its New Wave electroencephalogram (EEG) ...
("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) today announced that its wholly owned subsidiary, Neural Cloud Solutions Inc. ("Neural Cloud"), entered into a reseller agreement on March ...
Nihon Kohden India, a wholly-owned subsidiary of Japan’s Nihon Kohden Corporation has announced the Indian launch of the Life ...
Zeto, Inc., a medical technology company dedicated to making brain health insights through EEG a foundational vital sign in ...
New Wave marks the Raleigh, North Carolina-based company’s latest EEG system for outpatient clinics and homes. Zeto says it addresses the long waits for EEG appointments and shortages of EEG ...
The EMT was shocked that I wasn't having a heart attack after he did an EKG." "He very calmly told me that the symptoms for ...
An older man presents with acute coronary syndrome and a large atrial myxoma, complicating diagnosis and guiding decisions on revascularization and surgery.
The FDA clearance of the Zeto New Wave (TM) marks Zeto's third FDA-cleared device, alongside Zeto WR19 and Zeto ONE. Zeto offers EEG solutions for critical and emergency care, academic research, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results